NDAQ
Q3 2026 EPS Estimate
$0.96
Jul 23, 2026 · Reports before open
Revenue Estimate
$1.42B
FY2026E EPS$3.95
FY2027E EPS$4.45

Analyst Sentiment

Wall St. Consensus
Buy
21 analysts·High coverage
68
Score
15 Buy (71%)6 Hold (29%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1571%
Hold
629%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$109.00
+38.7%
Consensus
$114.00
+45.1%
Bull
$120.00
+52.7%
12-Month Target Range21 analysts
$109.00$114.00$120.00
Current $78.56Consensus
Current Price
$78.56
Upside to Consensus
$35.44

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+8.45%
EPS+12.72%
FY2028
Rev+8.05%
EPS+14.38%
FY2029
Rev+7.46%
EPS+11.35%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$5.77B$6.26B$6.76B$7.27B$7.38B
Low$5.65B$5.99B$6.75B$7.08B$7.19B
High$5.88B$6.38B$6.77B$7.40B$7.52B
EBITDA Avg$1.92B$2.09B$2.25B$2.42B$2.46B
Low$1.88B$2.00B$2.25B$2.36B$2.40B
High$1.96B$2.13B$2.26B$2.47B$2.51B
EBIT Avg$1.58B$1.71B$1.85B$1.98B$2.02B
Low$1.54B$1.63B$1.84B$1.93B$1.96B
High$1.61B$1.74B$1.85B$2.02B$2.05B
Net Income Avg$1.91B$2.09B$2.97B$3.27B$3.49B
Low$1.85B$2.06B$2.70B$3.16B$3.37B
High$2.37B$2.67B$3.24B$3.35B$3.57B
EPS Avg$3.95$4.45$5.09$5.67$6.05
Low$3.22$3.57$4.68$5.48$5.85
High$4.11$4.63$5.61$5.80$6.19
Analysts (Rev / EPS)11 / 1111 / 117 / 43 / 26 / 2
Quarterly
MetricQ2 2026Q3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$1.42B$1.43B$1.51B$1.50B$1.54B$1.54B$1.62B$1.63B
Low$1.40B$1.40B$1.48B$1.47B$1.51B$1.51B$1.59B$1.60B
High$1.46B$1.45B$1.53B$1.53B$1.57B$1.57B$1.65B$1.66B
EBITDA Avg$474M$478M$502M$500M$515M$514M$541M$542M
Low$467M$468M$492M$490M$505M$504M$531M$532M
High$487M$484M$512M$509M$525M$524M$551M$553M
EBIT Avg$388M$391M$411M$409M$422M$421M$443M$444M
Low$382M$383M$403M$401M$414M$413M$434M$436M
High$399M$397M$419M$417M$430M$429M$451M$453M
Net Income Avg$542M$562M$596M$604M$621M$631M$670M$688M
Low$514M$533M$581M$589M$605M$615M$653M$671M
High$559M$579M$611M$619M$636M$647M$687M$705M
EPS Avg$0.95$0.98$1.04$1.06$1.09$1.10$1.17$1.20
Low$0.90$0.93$1.02$1.03$1.06$1.08$1.14$1.17
High$0.98$1.01$1.07$1.08$1.11$1.13$1.20$1.23
Analysts (Rev / EPS)8 / 118 / 117 / 44 / 46 / 54 / 87 / 43 / 5

Earnings Surprises

Recent Analyst Actions

Jun 11, 2026Redburn Partners
Nasdaq price target raised to $110 from $109 at Rothschild & Co Redburn
Target:$110.00
+26.8%from $86.72
Apr 24, 2026Loop Capital Markets
Nasdaq price target raised to $113 from $109 at BofA
Target:$113.00
+29.8%from $87.04
Feb 25, 2026Raymond James
Raymond James Reiterates Outperform Rating on Nasdaq OMX Group Inc. (NDAQ)
Target:$109.00
+29.8%from $83.99
Jan 30, 2026Morgan Stanley
Nasdaq price target raised to $116 from $113 at Morgan Stanley
Target:$116.00
+17.9%from $98.42
Jan 15, 2026Morgan Stanley
Nasdaq price target raised to $113 from $111 at Morgan Stanley
Target:$113.00
+12.0%from $100.91
Jan 12, 2026UBS
Nasdaq price target raised to $120 from $115 at UBS
Target:$120.00
+20.8%from $99.37
Jan 8, 2026Barclays
Nasdaq price target raised to $115 from $114 at Barclays
Target:$115.00
+14.5%from $100.40
Dec 22, 2025Morgan Stanley
Nasdaq price target raised to $111 from $110 at Morgan Stanley
Target:$111.00
+16.4%from $95.36
Dec 12, 2025Barclays
Nasdaq price target raised to $114 from $109 at Barclays
Target:$114.00
+21.5%from $93.86
Nov 20, 2025Morgan Stanley
Nasdaq upgraded to Overweight from Equal Weight at Morgan Stanley
Target:$110.00
+27.9%from $86.02
Oct 22, 2025Barclays
Nasdaq price target raised to $109 from $108 at Barclays
Target:$109.00
+20.7%from $90.33
Oct 13, 2025Raymond James
Nasdaq price target raised to $100 from $99 at Raymond James
Target:$100.00
+12.5%from $88.90
Oct 9, 2025RBC Capital
Nasdaq to report 'solid beat', says RBC Capital
Target:$108.00
+19.8%from $90.14
Oct 8, 2025Barclays
Nasdaq price target lowered to $108 from $109 at Barclays
Target:$108.00
+22.1%from $88.44
Oct 1, 2025Morgan Stanley
Nasdaq price target raised to $90 from $86 at Morgan Stanley
Target:$90.00
+3.3%from $87.10
Jul 9, 2025Raymond James
Nasdaq price target raised to $96 from $84 at Raymond James
Target:$96.00
+7.2%from $89.58
Jun 17, 2025Oppenheimer
Nasdaq price target raised to $96 from $85 at Oppenheimer
Target:$96.00
+11.7%from $85.95
Jan 9, 2025Raymond James
Nasdaq price target raised to $84 from $83 at Raymond James
Target:$84.00
+10.0%from $76.36
Oct 14, 2024Raymond James
Raymond James Upgrades Nasdaq OMX Group Inc. (NDAQ) to Outperform
Target:$82.00
+14.5%from $71.62
Sep 26, 2024RBC Capital
Nasdaq initiated with an Outperform at RBC Capital
Target:$88.00
+21.3%from $72.56
Sep 4, 2024Morgan Stanley
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Target:$55.00
-25.2%from $73.51
Sep 4, 2024Bank of America Securities
Nasdaq upgraded to Buy from Underperform at BofA
Target:$90.00
+26.1%from $71.39
Jul 30, 2024Oppenheimer
Nasdaq OMX Group Inc. (NDAQ) PT Raised to $78 at Oppenheimer
Target:$78.00
+12.8%from $69.15
May 14, 2024Argus Research
Nasdaq OMX Group Inc. (NDAQ) PT Raised to $66 at Argus
Target:$66.00
+8.9%from $60.62
Apr 12, 2024Oppenheimer
Nasdaq OMX Group Inc. (NDAQ) PT Raised to $72 at Oppenheimer
Target:$72.00
+14.2%from $63.06
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.